section name header

Pronunciation

NOR-ep-i-nef-rin

Classifications

Therapeutic Classification: vasopressors

Indications

High Alert


Action

  • Stimulates alpha-adrenergic receptors located mainly in blood vessels, causing constriction of both capacitance and resistance vessels.
  • Also has minor beta-adrenergic activity (myocardial stimulation).
Therapeutic effects:
  • Increased BP.
  • Increased cardiac output.

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Concentrates in sympathetic nervous tissue. Does not cross the blood-brain barrier but readily crosses the placenta.

Metabolism/Excretion: Taken up and metabolized rapidly by sympathetic nerve endings.

Half-Life: Unknown.

Time/Action Profile

(effects on BP)

ROUTEONSETPEAKDURATION
IVimmediaterapid1–2 min





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: arrhythmia, bradycardia, chest pain, hypertension

Endo: hyperglycemia

F and E: metabolic acidosis

GU: urine output, renal failure

Local: phlebitis at IV site

Neuro: anxiety, dizziness, headache, insomnia, restlessness, tremor, weakness

Resp: dyspnea

Misc: fever

Interactions

Drug-drug:

Route/Dosage

Availability

(Generic available)

Assessment

Toxicity and Overdose:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Levophed